Titan Pharmaceuticals Stock Investor Sentiment
| TTNP Stock | USD 7.01 0.31 4.23% |
Slightly above 62% of Titan Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Titan Pharmaceuticals stock suggests that many investors are alarmed at this time. Titan Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Titan Pharmaceuticals. The current market sentiment, together with Titan Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Titan Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Titan Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Titan daily returns and investor perception about the current price of Titan Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Titan |
Titan Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Titan Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Titan Pharmaceuticals that are available to investors today. That information is available publicly through Titan media outlets and privately through word of mouth or via Titan internal channels. However, regardless of the origin, that massive amount of Titan data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Titan Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Titan Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Titan Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Titan Pharmaceuticals alpha.
Titan Pharmaceuticals Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Titan Pharmaceuticals Regains Compliance with Nasdaq Listing - TipRanks.com - TipRanks | 01/26/2024 |
2 | StockNews.com Begins Coverage on Titan Pharmaceuticals | 02/15/2024 |
3 | Titan Pharmaceuticals Coverage Initiated at StockNews.com | 02/29/2024 |
4 | Acquisition by Greenberg Eric Howard of 25000 shares of Titan Pharmaceuticals at 1.52 subject to Rule 16b-3 | 03/06/2024 |
5 | When the Price of Talks, People Listen - Stock Traders Daily.com | 03/07/2024 |
6 | Disposition of tradable shares by Choong Choon Hau of Titan Pharmaceuticals at 9.32 subject to Rule 16b-3 | 03/18/2024 |
7 | Acquisition by Joseph Akers of 25000 shares of Titan Pharmaceuticals at 4.02 subject to Rule 16b-3 | 03/26/2024 |
8 | Disposition of tradable shares by Flores Francisco of Titan Pharmaceuticals subject to Rule 16b-3 | 04/02/2024 |
9 | Titan Pharmaceuticals Overhauls Leadership, Settles with Ex-Directors - TipRanks.com - TipRanks | 04/03/2024 |
Check out Titan Pharmaceuticals Hype Analysis, Titan Pharmaceuticals Correlation and Titan Pharmaceuticals Performance. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.